Key Considerations for Commercializing a Compound - - BioPharm International

ADVERTISEMENT

Key Considerations for Commercializing a Compound


blog comments powered by Disqus


Joerg Zimmerman, director of process development and implementation at Vetter discusses the need to think carefully about the commercialization efforts that must be applied to a compound under development. Providing real world examples, Zimmerman runs through the technical challenges that biotech companies commonly face in drug development and offers some sound advice to facilitate the process. Zimmerman also talks on the regulatory focus on considering biological formulations in prefilled syringes as combination products and the need to establish compatibility at an early stage in development. Posted Feb. 2012.

Related article: Playing the Drug Development Game

ADVERTISEMENT

ADVERTISEMENT

J&J Speeds Ebola Vaccine Development and Expands Production
October 24, 2014
Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Manufacturing Challenges of mAb Production: CHO or Plant Cells?
October 24, 2014
Celgene and Sutro Partner on ADC Development
October 24, 2014
GSK Accelerates Ebola Vaccine Development
October 24, 2014
Author Guidelines

Click here